EMPLOYMENT AGREEMENTEmployment Agreement • February 10th, 2023 • Teva Pharmaceutical Industries LTD • Pharmaceutical preparations
shall have appeared in any printed publication or patent of a third party or shall have become a part of the public knowledge except as a result of a breach of this Agreement by Executive; or (iii) shall have been received by Executive from a third party having no obligation to the Company.
AMENDMENT TO SENIOR UNSECURED SUSTAINABILITY-LINKED REVOLVING CREDIT AGREEMENTRevolving Credit Agreement • February 10th, 2023 • Teva Pharmaceutical Industries LTD • Pharmaceutical preparations • New York
This AMENDMENT to the Senior Unsecured Sustainability-Linked Revolving Credit Agreement, dated as of February 6, 2023 (this “Amendment”), is made and entered into by and among TEVA PHARMACEUTICAL INDUSTRIES LIMITED, an Israeli company registered under no 52-0013-954, the registered address of which is at Dvora HaNevia St. 124, Tel Aviv, Israel (the “Company” or “Parent”), TEVA PHARMACEUTICALS USA, INC., a Delaware corporation, the principal office of which is at 400 Interpace Parkway, Building A, Parsippany, New Jersey 07054, United States of America (“Teva USA” or the “US Borrower”), TEVA PHARMACEUTICAL FINANCE NETHERLANDS II B.V., a private company with limited liability (besloten vennootschap met beperkte aansprakelijkheid) incorporated under the laws of the Netherlands, with its official seat (statutaire zetel) in Amsterdam, the Netherlands, having its office at Piet Heinkade 107, 1019GM Amsterdam, the Netherlands and registered with the Dutch trade register under number 59012161 (
Private and confidential To: Eric Drape Subject: Extension letter to International Assignment as stated in Employment Agreement dated March 12, 2020 (the “Agreement”) The parties mutually agree to extend the undersigned international assignment until...Teva Pharmaceutical Industries LTD • February 10th, 2023 • Pharmaceutical preparations
